 |  | CURRENT Diagnosis & Treatment: PediatricsChapter 37. Antimicrobial TherapyJohn W. Ogle | |
Sections: Antimicrobial Susceptibility Testing, Alteration of Dose & Measurement of Blood Levels, The Use of New Antimicrobial Agents, Prophylactic Antimicrobial Agents, Initial Empiric Antimicrobial Choices for Selected Conditions, Specific Antimicrobial Agents, Penicillins, Glycopeptide Agents, Oxazolidinones, Quinupristin–Dalfopristin, Cephalosporins, Aztreonam, Carbapenems, Macrolides & Azalides, Clindamycin, Sulfonamides, Tetracyclines, Aminoglycosides, Fluoroquinolones, Metronidazole, Daptomycin, References.
Excerpt:"Antimicrobial therapy of infections is arguably the most important scientific development of 20th-century medicine. It contributes significantly to the quality of life of many people and reduces the morbidity and mortality due to infectious disease. The remarkable success of antimicrobial therapy has been achieved with comparatively little toxicity and expense. The relative ease of administration and the widespread availability of these drugs have led many to adopt a philosophy of broad-spectrum empiric antimicrobial therapy for many common infections...."
The content above is only an
excerpt. For full access, log into an existing user account below, purchase an annual subscription, or
purchase a short-term subscription to the complete website.
offers pediatrics students,
educators, and practioners access to leading McGraw-Hill texts, interactive imaging
content, exclusive multimedia, and flexible curricular tools.
Timed access to all of AccessPediatrics
24 hours for $29.95
48 hours for $49.95
Or